AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
38 hedge funds and large institutions have $8.81M invested in Agile Therapeutics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
86% less capital invested
Capital invested by funds: $63.4M → $8.81M (-$54.6M)
Holders
38
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$169K | |
| 2 | +$54K | |
| 3 | +$38K | |
| 4 |
WS
Wedbush Securities
Los Angeles,
California
|
+$25K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$24.7K |
Top Sellers
| 1 | -$4.66M | |
| 2 | -$3.35M | |
| 3 | -$1.35M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$666K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$393K |